EU health regulator supports Pfizer’s Abrysvo vaccine for infants, older adults
EMA’s Committee for Medicinal Products for Human Use (CHMP) supported the approval based on the data from two…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Jul 23
EMA’s Committee for Medicinal Products for Human Use (CHMP) supported the approval based on the data from two…
24 Jul 23
7MW3711 is developed by Mabwell's next-generation antibody-drug conjugate platform IDDC
24 Jul 23
Following a meeting yesterday, the U.S. Food and Drug Administration (FDA) placed a partial clinical hold on the…
21 Jul 23
The FDA approval was based on the data from the QuANTUM-First trial in which the Vanflyta combination reduced…
21 Jul 23
The deal will give $125m to Recludix Pharma in near-term payments from the French pharmaceutical firm in addition…
21 Jul 23
Combined with the Ion Torrent Genexus Integrated Sequencer, new assays deliver valuable genomic insights in the field of…
21 Jul 23
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana,…
21 Jul 23
Funding Will Support the Re-Engagement of Diagnosed but Untreated People Living with HCV and HBV in the United…
20 Jul 23
According to the trial's primary outcome measures, CoronaTcP showed a satisfactory safety profile, with no serious adverse events…
20 Jul 23
The Series B funding round was led by Bioluminescence Ventures, with participation from KdT Ventures, Piedmont Capital, and…